Literature DB >> 7985408

Genetic heterogeneity of the attachment glycoprotein G among group A respiratory syncytial viruses.

M C Sanz1, O M Kew, L J Anderson.   

Abstract

Fifteen independent group A respiratory syncytial virus (RSV) isolates were compared by sequencing a 300-nucleotide interval encoding a variable region of the attachment glycoprotein G. The viruses compared included the reference strains Long (USA 1956), A2 (Australia 1961), and 669 (Sweden 1959), along with 13 clinical isolates obtained at different times and locations throughout the United States. Representatives of all six antigenic subgroups, recognized by reactivity patterns with monoclonal antibodies, were compared. The maximum sequence heterogeneity within the G glycoprotein region compared was 15.7% of nucleotide sequences and 26% of amino acid sequences, more than twice the difference observed between Long and A2. Half of the nucleotide changes encoded amino acid substitutions, possibly indicating that the protein interval compared was subject to immune selection. Because the ratio of nucleotide to amino acid substitutions was nearly constant for all degrees of genetic divergence, the potential range of sequence divergence among group A RSV has probably not yet been attained. There was little correlation between the patterns of reactivity against a panel of monoclonal antibodies and sequence relationships among the 15 isolates. The sequence information showed multiple genotypes circulating simultaneously in the same community and very similar genotypes circulating in widely separated communities and during different years. Genetic analyses of RSV strains can provide important information about the relationships between RSV infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7985408     DOI: 10.1016/0168-1702(94)90103-1

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein.

Authors:  Kalina T Zlateva; Philippe Lemey; Elien Moës; Anne-Mieke Vandamme; Marc Van Ranst
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 2.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

Authors:  Nicholas W Lukacs; Martin L Moore; Brian D Rudd; Aaron A Berlin; Robert D Collins; Sandra J Olson; Samuel B Ho; R Stokes Peebles
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

4.  Strain-specific reverse transcriptase PCR assay: means to distinguish candidate vaccine from wild-type strains of respiratory syncytial virus.

Authors:  H Zheng; T C Peret; V B Randolph; J C Crowley; L J Anderson
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Circulating strains of human respiratory syncytial virus in central and south America.

Authors:  Merly Sovero; Josefina Garcia; Tadeusz Kochel; V Alberto Laguna-Torres; Jorge Gomez; Wilson Chicaiza; Melvin Barrantes; Felix Sanchez; Mirna Jimenez; Guillermo Comach; Ivette Lorenzana de Rivera; Ana E Arango; Roberto Agudo; Eric S Halsey
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

6.  First report of two consecutive respiratory syncytial virus outbreaks by the novel genotypes ON-1 and NA-2 in a neonatal intensive care unit.

Authors:  Daniella Gregoria Bomfim Prado da Silva; Flávia Jacqueline Almeida; Mariana Volpe Arnoni; Marco Aurélio Palazzi Sáfadi; Marcelo Jenne Mimica; Daniel Jarovsky; Gabriela Pereira de Almeida Rossetti; Mauricio Magalhães; Danielle Bruna Leal de Oliveira; Luciano Matsumiya Thomazelli; Thais Cristina Colmanetti; Edison Luiz Durigon; Eitan Naaman Berezin
Journal:  J Pediatr (Rio J)       Date:  2018-12-12       Impact factor: 2.990

7.  Respiratory syncytial virus epidemic periods in an equatorial city of Brazil.

Authors:  Fernanda E A Moura; Anne C B Perdigão; Joyce F Ribeiro; Caroline M G D Florêncio; Francisco M S Oliveira; Samuel A R Pereira; Viviane F Botosso; Marilda M Siqueira; Luciano M Thomazelli; Raquel N Caldeira; Danielle B L Oliveira; Edison L Durigon
Journal:  Influenza Other Respir Viruses       Date:  2013-03-20       Impact factor: 4.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.